GRADE & PURITYMoligand™?Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Revisões
Avaliações dos Clientes
Application Protocols
Only tested applications and conditions from the product data should be listed. No application protocols are provided for LY3410738 in the listing.
Tested applications: Not specified for this item.
Recommended concentrations/dilutions: Not specified for this item.
Positive controls/standards: Not specified for this item.
For protocol development, refer to the Reaction & Applications and Solvent Selection sections for general best practices, and consult the CoA/Spec Sheet or literature for any item-specific guidance.
Biological Roles
Item-specific biological function/target information is not provided in the product data for LY3410738. The following notes outline how small-molecule library members are typically used in biological research.
Potential roles (general; not item-specific): Small molecules may act as ligands for enzymes, receptors, transporters, or protein–protein interaction surfaces, modulating activity through orthosteric, allosteric, or covalent mechanisms. They can also perturb cellular pathways to serve as chemical probes in target validation.
Selectivity and off-targets: Polypharmacology is common; orthogonal assays and chemoproteomic profiling help define on-target effects.
ADME-related roles: Compounds can serve as tool molecules to explore permeability, efflux, metabolic stability, or transporter interactions in vitro.
Important caveats:
Without item-specific target data, do not assume mechanism, potency, or selectivity. Establish these empirically with appropriate controls and concentration–response studies.
Intrinsic fluorescence/absorbance or redox activity can artifactually influence readouts; include counterscreens to detect assay interference (e.g., aggregators, PAINS alerts based on structural motifs once known).
Summary: Treat LY3410738 as an uncharacterized research ligand unless supported by target-verified data from the CoA, literature, or internal validation.
Buffer Applications
Not typically applicable. LY3410738 is a discrete small molecule, not a buffering agent or buffer system component.
Practical notes for assay buffers (general; not item-specific):
Prepare compound stocks in DMSO and dilute into assay buffer to a low final DMSO percentage compatible with the biology (commonly 0.1–1% v/v in biochemical assays; lower for cellular assays).
Select buffer pH near the target’s optimal activity and consider compound ionization (pKa) once known to maximize solubility and maintain consistent free concentration.
Include low levels of nonionic detergent (e.g., 0.01–0.05% Tween-20) to mitigate colloidal aggregation where relevant.
Filter buffers (0.22 µm) and degas as needed for biophysical methods (SPR/BLI).
Item-specific buffer roles, pH ranges, or recipes: Not specified for this item; refer to CoA/Spec Sheet if provided.
Green Alternatives
While LY3410738 is a discrete small molecule (not a solvent or bulk reagent), greener practices can be applied to its handling and use in screening campaigns.
Greener solvent choices for stocks and assays (general, not item-specific):
Prefer aqueous buffer with minimal cosolvent when solubility permits.
DMSO is commonly used for stocks due to low volatility and good solvency; keep final assay DMSO concentration as low as feasible (e.g., ≤0.1–0.5% v/v in cell assays) to reduce solvent burden.
Avoid chlorinated solvents (e.g., dichloromethane) for routine handling; use acetonitrile or ethanol when compatible with analytical methods.
Operational improvements:
Miniaturize assays (384–1536-well) to reduce material and solvent usage.
Use sealed plates to limit evaporation and emissions.
Implement acoustic dispensing to reduce plastic tips and DMSO consumption.
Comparison (general; not item-specific):
DMSO vs DMF: DMSO has more favorable toxicological and environmental profile and is preferred for screening stocks.
ACN vs MeOH for analytics: ACN often yields lower viscosity and improved chromatographic performance, allowing reduced solvent volumes; MeOH may be preferable from a renewable sourcing standpoint. Balance method performance with green metrics.
Waste considerations:
Segregate DMSO/organic waste from aqueous streams; apply on-plate quenching to minimize hazardous waste volumes.
Adopt DoE approaches to minimize repeat experiments and resource use.
Pharmaceutical Uses
No pharmacopeial or excipient information is provided. LY3410738 is offered for research use only and is not indicated for clinical or diagnostic applications.
General context for small-molecule research compounds (not item-specific):
May serve as tool compounds in pre-formulation studies such as solubility screening, salt/solid-form exploration, or early stability assessments to inform medicinal chemistry optimization.
Can be used in in vitro developability panels (solubility, permeability, pH stability) to triage chemical series.
Regulatory and compliance:
Not produced to GMP specifications unless explicitly stated; no claims of compendial compliance (USP/EP/JP) are made in the product data.
Any use in manufacturing or clinical settings would require separate sourcing and qualification.
Item-specific excipient/formulation roles: Not specified for this item; refer to CoA/Spec Sheet.
Physical Properties
Item-specific physicochemical data are not provided in the listing. Do not treat the following placeholders as specifications.
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Melting point: Not specified for this item; refer to CoA/Spec Sheet.
Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
Density: Not specified for this item; refer to CoA/Spec Sheet.
Refractive index: Not applicable/unknown for solids; Not specified for this item; refer to CoA/Spec Sheet.
Solubility: Not specified for this item; refer to CoA/Spec Sheet.
LogP/logD: Not specified for this item; refer to CoA/Spec Sheet.
pKa(s): Not specified for this item; refer to CoA/Spec Sheet.
General guidance (literature/practice, not item-specific):
Small-molecule screening compounds are commonly supplied as solids with good solubility in DMSO (e.g., 10–50 mM stock preparation). Actual solubility varies and must be empirically verified.
If aqueous assay compatibility is needed, assess DMSO cosolvent tolerance (commonly 0.1–1% v/v in biochemical assays) and consider adding surfactant (e.g., 0.01% Tween-20) if aggregation is suspected.
Hygroscopicity and polymorphism can affect measured melting points; use DSC/TGA if thermal behavior is critical.
Measurement tips (general):
Determine kinetic/thermodynamic solubility by shake-flask in assay-relevant buffer; analyze by HPLC-UV or LC–MS.
For ionizable compounds, measure pKa (potentiometric or UV-metric) to guide buffer selection and cell permeability predictions.
Quality and Grades
Grade information provided: Moligand™.
What Moligand™ signifies (general description): A screening-oriented grade for small molecules intended for biochemical/biophysical assays, cellular studies (research use), and cheminformatics workflows. Typically emphasizes identity confirmation and assay-ready handling over ultratrace impurity limits associated with analytical or semiconductor grades. This is a general description and not a specification for this specific item.
Item-specific quality parameters: Not specified for this item; refer to CoA/Spec Sheet for purity method (e.g., HPLC/UPLC area%), residual solvent limits, water content, and structural confirmation (LC–MS/NMR).
Stabilizers/Inhibitors: Not specified for this item; refer to CoA/Spec Sheet.
UV cutoff/fluorescence background: Not specified for this item; refer to CoA/Spec Sheet. For optical assays, confirm intrinsic absorbance/fluorescence spectra to avoid assay interference.
Practical implications:
Suitable for hit finding and SAR exploration when used with appropriate controls (vehicle, positive control, counterscreens).
If required for regulated studies or trace analysis, additional purification or documentation may be necessary.
Recommended incoming QC (best practice):
Verify identity by LC–MS; check purity by HPLC with orthogonal methods if the assay is sensitive to trace impurities.
Confirm salt form/stoichiometry and water content if mass-based dosing is used.
Trace metals/peroxides/UV cutoffs: Not specified for this item; refer to CoA/Spec Sheet.
Reaction and Applications
This product is supplied as a small-molecule library member for research use; it is not primarily positioned as a synthetic reagent. Accordingly, conventional “reaction chemistry” use cases (e.g., as a base, catalyst, coupling partner) are generally not applicable.
Applicable research applications (general guidance for Moligand™ library members):
Biochemical assays: enzyme inhibition/activation studies, equilibrium binding (e.g., fluorescence polarization, SPR, MST, DSF), and mechanistic enzyme kinetics. Validate DMSO tolerance and include counterscreens to detect assay interference.
Cell-based assays: phenotypic screens, pathway modulation, reporter assays. Titrate concentrations (e.g., 8–12-point curves) to establish potency and cytotoxicity windows.
Target deconvolution: use chemoproteomics, CETSA, or CRISPR modulation with orthogonal readouts to evaluate on-target activity versus polypharmacology.
ADME profiling: solubility, stability (buffer, microsomes), permeability (PAMPA/MDCK), and plasma protein binding to guide follow-up studies.
Not typically applicable for this item:
Role as a stoichiometric reagent, monomer, or common building block in synthesis.
Practical tips (general):
Prepare concentrated DMSO stocks (e.g., 10 mM), aliquot to minimize freeze–thaw and moisture uptake, and store per product guidance.
Check intrinsic fluorescence/absorbance to avoid optical assay artifacts; include detergent if aggregation is suspected (AMPK/kinase assay best practices).
Reaction Conditions
Not typically applicable. LY3410738 is not intended to function as a reagent or substrate for general synthetic reactions in this catalog context.
General guidance relevant to biological testing solutions (not item-specific):
Stock preparation: Commonly 10–50 mM in anhydrous DMSO. Verify solubility empirically; adjust concentration accordingly.
Storage and handling of solutions: Protect from moisture; aliquot to minimize freeze–thaw cycles. Use amber vials if the compound is light-sensitive (status not specified here).
Assay incubation conditions: Define time, temperature, and mixing based on the biological system. For enzyme assays, typical ranges are 25–37°C with 15–60 min preincubation if time-dependent inhibition is suspected.
Analytical conditions: HPLC or UPLC using reverse-phase C18 with water (0.1% formic acid) and acetonitrile/methanol gradients is a common starting point for purity assessment. Optimize detection wavelength based on UV spectrum once known.
Item-specific reaction conditions, catalysts, or yields: Not applicable/not specified for this item.
Safety and Handling
Safety data specific to LY3410738 are not provided in the listing. Treat as a research chemical of unknown hazards.
Item-specific data (from Product Data):
GHS classification: Not specified for this item; refer to SDS.
Signal word / H-statements / pictograms: Not specified for this item; refer to SDS.
Storage conditions: Room temperature (provided). Avoid extremes of temperature and humidity unless otherwise noted on the CoA.
General laboratory precautions (not item-specific; follow SDS once available):
PPE: Wear lab coat, safety glasses, and appropriate chemically resistant gloves (e.g., nitrile). Handle powders in a fume hood to avoid inhalation.
Avoid contact with skin, eyes, and clothing; prevent dust/aerosol formation.
Incompatibilities: Strong oxidizers and strong acids/bases may be incompatible with many organic compounds; segregate until specific compatibility is known.
First aid (overview): If inhaled, move to fresh air; if on skin, wash with soap and water; if in eyes, rinse cautiously with water for several minutes; if ingested, rinse mouth and seek medical attention. Always consult the SDS for authoritative instructions.
Spill response: For small spills of solids, gently cover with damp disposable towels to minimize dust, collect into suitable waste; for DMSO solutions, absorb on inert material and dispose according to institutional hazardous waste protocols.
Waste: Dispose via licensed chemical waste contractor. Do not release to drains.
Note: Peroxide formation, pyrophoricity, or other special hazards are not indicated for this item; however, confirm via SDS before scale-up or aerosol-generating operations.
Solvent Selection
Item-specific solubility is not provided. The following guidance reflects common practice for small-molecule screening compounds and should be verified experimentally for LY3410738.
Primary stock solvent (general): DMSO is typically preferred due to broad solvating power and assay compatibility at low percentages.
Secondary solvents: DMF, ethanol, methanol, or acetonitrile may be used when compatible with the assay; verify stability and background signals.
Aqueous compatibility: Many screening compounds require cosolvent for aqueous buffers. Typical final DMSO in biochemical assays: 0.1–1% v/v; in cell assays, ≤0.1–0.5% v/v is often targeted, but tolerance must be determined per cell line.
Solvent properties (general references):
DMSO: high polarity/protic-like behavior, miscible with water, low volatility; can affect cell membranes and enzyme kinetics at higher %.
Acetonitrile: polar aprotic, miscible with water, low viscosity; good for HPLC sample prep.
Ethanol/Methanol: polar protic; may interfere with some enzymes/receptors.
Small comparison (general; not item-specific):
DMSO vs DMF: DMSO is more biocompatible at low %; DMF may have higher cytotoxicity.
DMSO vs ACN: DMSO better for stocks; ACN evaporates faster and is often used in analytical injections.
Practical tips:
Warm (25–37°C) and vortex/sonicate to assist dissolution; avoid prolonged heating.
Filter 0.2 µm if particles persist and filtration is compatible with the compound.
Record exact solvent lot and water content for reproducibility.
Shipped in: Not specified for this item; refer to CoA/Spec Sheet.
Reconstitution guidance (general; verify empirically for this item):
Prepare a concentrated stock solution in anhydrous DMSO (e.g., 10–50 mM) if soluble; vortex and sonicate gently. If solubility is limited, consider lower concentration or alternate solvent (DMF, ethanol) compatible with your assay.
Filter (0.2 µm PTFE) if particulate persists and filtration is compatible.
Dispense single-use aliquots to minimize freeze–thaw and moisture uptake. Although room-temperature storage is indicated for the neat material, frozen storage (e.g., −20°C) of DMSO stocks is commonly used to enhance stability; confirm stability experimentally for this item.
Handling tips:
Allow frozen aliquots to thaw at room temperature, mix thoroughly, and inspect for precipitation before use.
Record preparation date, solvent, and concentration on each aliquot; periodically reassess purity by HPLC/LC–MS for long-term studies.
Specifications not provided for this item:
Water content, residual solvents, stabilizers/inhibitors, light sensitivity, and exact shelf life are not specified; refer to CoA/Spec Sheet and SDS for authoritative guidance.
Structure and Identity
Overview: LY3410738 is listed as a small-molecule library member (Moligand™ grade) intended for research screening and discovery workflows.
Product name: LY3410738
CAS: 2230263-60-0 (provided)
PubChem CID: 135125140 (provided)
InChIKey: 4001 (provided as-is in product data)
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
Structural features (general notes):
Item-specific structural motifs are not provided in the product data. Many Moligand™ library members are drug-like small molecules that typically contain heteroatoms (N/O/S), ring systems, and polar functionality amenable to dissolution in DMSO for screening. This is general information and not a specification for this item.
2D structure description (general):
Not specified for this item; refer to CoA/Spec Sheet. If structure is required for cheminformatics or docking, retrieve the record using the provided CAS or CID and verify against the supplier’s CoA to ensure correct tautomer/salt/isomer before use.
Identity confirmation recommendations (general best practice):
Cross-check CAS and supplier SKU on receipt; verify by LC–MS and 1H NMR where critical.
If multiple stereochemical forms exist in external databases, confirm the exact stereochemistry with the CoA prior to biological evaluation.
Synthetic Utility
This listing is for a discrete small-molecule research ligand rather than a general-purpose synthetic reagent. Therefore, its use as a coupling partner, catalyst, or protecting group reagent is not typical.
General notes (not item-specific):
If the structure is available and synthetic analogs are desired, the compound can serve as a reference standard for SAR and analytical benchmarking (LC–MS retention, NMR signatures) while exploring scaffold modifications.
Solid-form studies (polymorph, solvate, salt forms) may be conducted to support medicinal chemistry campaigns; results inform purification and crystallization strategies for analogs.
If the molecule contains functional handles (e.g., anilines, phenols, nitriles) as determined from structure, divergent analog synthesis can be planned via standard transformations (amide couplings, SNAr, cross-couplings). This requires confirmation of the exact structure from the CoA.
Recommendation:
Use LY3410738 as an analytical reference for purity/identity and as a comparator in biological assays; employ separate, purpose-built reagents for synthetic method development.
Target Specificity
Only item-specific data should be listed here. No target, epitope, or selectivity information is provided in the product data for LY3410738.
Target(s): Not specified for this item; refer to CoA/Spec Sheet and primary literature where applicable.
Mechanism of action: Not specified for this item.
Species selectivity: Not specified for this item.
Note: For small-molecule ligands, determine target engagement using orthogonal methods (e.g., CETSA, SPR/BLI, enzymatic IC50/Ki) and confirm in relevant species or cellular models.
Need help choosing the grade?
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
